Magna Pharmaceuticals, Inc.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1990-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.magnaweb.com
StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study
Phase 2
- Conditions
- Rhinitis, Seasonal, Allergic
- Interventions
- Drug: PSE 120 mg, CM 8 mg, Atr 0.36 mgDrug: PSE 120 mg, CM 8 mg, Atr 0.24 mgDrug: PSE 120 mg, CM 8 mg, Atr 0.12 mgDrug: PSE 120 mg, CM 8 mg
- First Posted Date
- 2014-03-10
- Last Posted Date
- 2014-05-30
- Lead Sponsor
- Magna Pharmaceuticals, Inc.
- Target Recruit Count
- 125
- Registration Number
- NCT02082054
- Locations
- ๐บ๐ธ
Clinical Research Atlanta, Stockbridge, Georgia, United States
๐บ๐ธFamily Allergy and Asthma Institute, Louisville, Kentucky, United States
๐บ๐ธNational Allergy, Asthma & Urticaria Centers of Charleston, PA, Charleston, South Carolina, United States
Trial of STAHIST in Seasonal Allergic Rhinitis
Phase 3
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: STAHISTDrug: Placebo
- First Posted Date
- 2011-02-10
- Last Posted Date
- 2011-09-02
- Lead Sponsor
- Magna Pharmaceuticals, Inc.
- Target Recruit Count
- 290
- Registration Number
- NCT01293201
- Locations
- ๐บ๐ธ
The South Bend Clinic, South Bend, Indiana, United States
๐บ๐ธNew Horizons Clinical Research, Cincinnati, Ohio, United States
๐บ๐ธCentral Texas Health Research, New Braunfels, Texas, United States
Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects
Phase 2
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: PlaceboDrug: STAHIST
- First Posted Date
- 2010-07-28
- Last Posted Date
- 2014-03-26
- Lead Sponsor
- Magna Pharmaceuticals, Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT01171664
- Locations
- ๐บ๐ธ
Family Allergy & Asthma Research Institute, Louisville, Kentucky, United States
๐บ๐ธThe South Bend Clinic, South Bend, Indiana, United States
Study of AHIST in Seasonal Allergic Rhinitis Patients
Phase 1
Withdrawn
- Conditions
- Rhinitis, Allergic, Seasonal
- Interventions
- Drug: AHIST NDC#58407-012-01
- First Posted Date
- 2009-11-05
- Last Posted Date
- 2014-03-06
- Lead Sponsor
- Magna Pharmaceuticals, Inc.
- Registration Number
- NCT01008397
- Locations
- ๐บ๐ธ
Family Allergy and Asthma Research Institute, Louisville, Kentucky, United States
Clinical Trial of STAHIST in Seasonal Allergic Rhinitis Patients
Phase 1
Completed
- Conditions
- Rhinitis, Allergic, Seasonal
- Interventions
- Drug: STAHIST NDC #58407-536-01
- First Posted Date
- 2009-07-03
- Last Posted Date
- 2010-12-08
- Lead Sponsor
- Magna Pharmaceuticals, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT00932256
- Locations
- ๐บ๐ธ
Family Allergy and Asthma Research Institute, Louisville, Kentucky, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath